Current state-of-the-art knowledge on the role of omega-3 fatty acids in the prevention of cardiovascular disease

CONCLUSIONS: The clinical studies and metaanalyses strongly point out that only EPA (icosapent ethyl), especially at dose of 4 g/d, is effective in reducing cardiovascular events in very high and high risk patients with hypertriglyceridemia. The use of EPA + DHA preparations in doses up to 1 g/d does not prevent recurrent cardiovascular events.PMID:33356055 | DOI:10.26444/aaem/126674

Source: Annals of Agricultural and Environmental Medicine : AAEM - December 28, 2020 Category: Environmental Health Authors: Longina K łosiewicz-Latoszek Barbara Cybulska Piotr Tyszko Source Type: research